Methylation of an ETS Site in the Intron Enhancer of the Keratin 18 Gene Participates in Tissue-Specific Repression
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The activities of ETS transcription factors are modulated by posttranscriptional modifications and cooperation with other proteins. Another factor which could alter the regulation of genes by ETS transcription factors is DNA methylation of their cognate binding sites. The optimal activity of the keratin 18 (K18) gene is dependent upon an ETS binding site within an enhancer region located in the first intron. The methylation of the ETS binding site was correlated with the repression of the K18 gene in normal human tissues and in K18 transgenic mouse tissues. Neither recombinant ETS2 nor endogenous spleen ETS binding activities bound the methylated site effectively. Increased expression of the K18 gene in spleens of transgenic mice by use of an alternative, cryptic promoter 700 bp upstream of the enhancer resulted in modestly decreased methylation of the K18 ETS site and increased RNA expression. Expression in transgenic mice of a mutant K18 gene, which was still capable of activation by ETS factors but was no longer a substrate for DNA methylation of the ETS site, was fivefold higher in spleen and heart. However, expression in other organs such as liver and intestine was similar to that of the wild-type gene. This result suggests that DNA methylation of the K18 ETS site may be functionally important in the tissue-specific repression of the K18 gene. Epigenetic modification of the binding sites for some ETS transcription factors may result in a refractory transcriptional response even in the presence of necessary trans-acting activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lewis, J. D., Meehan, R. R., Henzel, W. J., Maurer-Fogy, I., Jeppesen, P., Klein, F., & Bird, A. (1992) · Cell · doi:10.1016/0092-8674(92)90610-o · Cited by 1,371 · cited 1×
“Thus, DNA methylation provides a possible mechanism of altering the occupancy of regulatory elements associated with developmentally regulated genes, directly by changing the interaction between transcription factors and their binding sites or indirectly by altering chromatin conformation or competition with methyl-Cp…”
BackgroundThe ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence.
Karim, F. D., Urness, L. D., Thummel, C. S., Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., Maki, R. A., Gunther, C. V., & Nye, J. A. (1990) · Genes & Development · doi:10.1101/gad.4.9.1451 · Cited by 499
Self-citationNye, J. A., Petersen, J. M., Gunther, C. V., Jonsen, M. D., & Graves, B. J. (1992) · Genes & Development · doi:10.1101/gad.6.6.975 · Cited by 363 · cited 5×
“Thus, Ets-1 and Ets-2 cooperate with AP-1 (64) but also interact with other factors such as Pax5 (17); GABPa specifically binds its heteropolymeric partner, GABPb (7); Elk-1 interacts with SAP-1 to mediate gene activation in response to serum (61); and PU.1 interacts with NF-EM5 (55).”
BackgroundInfluentialHöller, M., Westin, G., Jiricny, J., & Schaffner, W. (1988) · Genes & Development · doi:10.1101/gad.2.9.1127 · Cited by 305 · cited 1×
“While the methylation of CpG dinucleotides of SP-1 binding sites does not prevent the binding of the transcription factor (24), other transcription factors are sensitive to the methylation state of the binding site (19, 32, 41, 66).”
BackgroundEffect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 271
Self-citationBrown, T. A., & McKnight, S. L. (1992) · Genes & Development · doi:10.1101/gad.6.12b.2502 · Cited by 265
Gaston, K., & Fried, M. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.6.901 · Cited by 99 · cited 3×
“The binding of both Ets-2 and GABP, two members of the ETS family of transcription factors, is sensitive to the methylation state of the CpG adjacent to the GGAA/T core recognition element shared by ETS family members (19, 41).”
BackgroundYokomori, N., Kobayashi, R., Moore, R., Sueyoshi, T., & Negishi, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5355 · Cited by 88 · cited 1×
“While the methylation of CpG dinucleotides of SP-1 binding sites does not prevent the binding of the transcription factor (24), other transcription factors are sensitive to the methylation state of the binding site (19, 32, 41, 66).”
Background
Cited by
Keratins and the Keratinocyte Activation Cycle
Freedberg, I. M., Tomic-Canic, M., Komine, M., & Blumenberg, M. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01327.x · Cited by 567
Ets target genes: past, present and future
Sementchenko, V. I., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204034 · Cited by 371
“…Keratin 18 F9 (embryonal EBS AGCGGATGTG m (Pankov et al., 1994a,b; Rhodes and carcinoma) Oshima, 1998) Keratin 18 Enhancer Liver Ets2 AGCGGATGTG meth (Umezawa et al., 1997) SPRR1A (keratinocyte Fibroblasts, EBS TGAGGAATGA d,m (Sark et al., 1998) differentiation) NIH3T3 TATTTCCTTG SPRR2A envelope…”
BackgroundKohyama, J., Abe, H., Shimazaki, T., Koizumi, A., Nakashima, K., Gojo, S., Taga, T., Okano, H., Hata, J.-I., & Umezawa, A. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.680411.x · Cited by 295
Self-citationReactivating the expression of methylation silenced genes in human cancer
Karpf, A. R., & Jones, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205602 · Cited by 264
In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells
Gojo, S. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00132-0 · Cited by 255
Metadata
- Authors
- Umezawa, A., Yamamoto, H., Rhodes, K., Klemsz, M. J., Maki, R. A., & Oshima, R. G.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1997-09
- Volume
- 17
- Issue
- 9
- Pages
- 4885-4894
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2272066499
- Cited by
- 47
- References
- 8
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.